 | 1 | CATALYST PHARMACEUTICALS INC. |  | 456.54% | 9.0 |  |
 | 2 | SIGA TECHNOLOGIES INC |  | 437.42% | 68.0 |  |
 | 3 | Sage Therapeutics Inc. |  | 421.92% | 238.0 |  |
 | 4 | CEN BIOTECH INC |  | 414.35% | 222.0 |  |
 | 5 | CORCEPT THERAPEUTICS INC |  | 324.58% | 2.0 |  |
 | 6 | Blueprint Medicines Corp |  | 293.49% | 184.0 |  |
 | 7 | VERTEX PHARMACEUTICALS INC MA |  | 275.77% | 11.0 |  |
 | 8 | REGENERON PHARMACEUTICALS INC. |  | 226.67% | 9.0 |  |
 | 9 | Jazz Pharmaceuticals plc |  | 211.97% | 5.0 |  |
 | 10 | Minerva Neurosciences Inc. |  | 210.29% | 262.0 |  |
 | 11 | BIOMARIN PHARMACEUTICAL INC |  | 208.98% | 31.0 |  |
 | 12 | UNITED THERAPEUTICS Corp |  | 199.66% | 33.0 |  |
 | 13 | ABBOTT LABORATORIES |  | 198.87% | 9.0 |  |
 | 14 | Lifevantage Corp |  | 197.95% | 18.0 |  |
 | 15 | China Health Industries Holdings Inc. |  | 196.78% | 8.0 |  |
 | 16 | Vanda Pharmaceuticals Inc. |  | 193.38% | -7.0 |  |
 | 17 | XBiotech Inc. |  | 189.90% | -16.0 |  |
 | 18 | Endo International plc |  | 181.80% | 17.0 |  |
 | 19 | XOMA Corp |  | 181.61% | 47.0 |  |
 | 20 | AbbVie Inc. |  | 171.65% | -1.0 |  |
 | 21 | Merck & Co. Inc. |  | 165.69% | 0.0 |  |
 | 22 | PROCYON CORP |  | 162.86% | 7.0 |  |
 | 23 | ANAPTYSBIO INC |  | 162.61% | 55.0 |  |
 | 24 | DURECT CORP |  | 159.98% | 82.0 |  |
 | 25 | EAGLE PHARMACEUTICALS INC. |  | 158.12% | 5.0 |  |
 | 26 | NATURES SUNSHINE PRODUCTS INC |  | 157.27% | 14.0 |  |
 | 27 | CASSAVA SCIENCES INC |  | 157.06% | 46.0 |  |
![]() | 28 | Greenwich LifeSciences Inc. |  | 153.63% | 0.0 |  |
![]() | 29 | Regen BioPharma Inc |  | 152.85% | 0.0 |  |
 | 30 | LUMOS PHARMA INC. |  | 148.75% | 0.0 |  |
 | 31 | Royalty Pharma plc |  | 148.38% | 0.0 |  |
![]() | 32 | Enochian Biosciences Inc |  | 143.79% | 7.0 |  |
 | 33 | ENANTA PHARMACEUTICALS INC |  | 137.69% | -20.0 |  |
![]() | 34 | PMV Pharmaceuticals Inc. |  | 137.23% | 0.0 |  |
![]() | 35 | GT Biopharma Inc. |  | 135.35% | 0.0 |  |
 | 36 | Pacira BioSciences Inc. |  | 131.91% | 32.0 |  |
 | 37 | ALX ONCOLOGY HOLDINGS INC |  | 129.84% | 0.0 |  |
 | 38 | Emergent BioSolutions Inc. |  | 129.61% | 18.0 |  |
 | 39 | Aadi Bioscience Inc. |  | 127.56% | 186.0 |  |
![]() | 40 | ALEXION PHARMACEUTICALS INC. |  | 123.39% | -15.0 |  |
 | 41 | Amphastar Pharmaceuticals Inc. |  | 123.04% | -14.0 |  |
 | 42 | OPKO HEALTH INC. |  | 122.10% | 32.0 |  |
 | 43 | BIODELIVERY SCIENCES INTERNATIONAL INC |  | 120.28% | 37.0 |  |
 | 44 | SUPERNUS PHARMACEUTICALS INC. |  | 118.23% | -10.0 |  |
 | 45 | INTEGRATED BIOPHARMA INC |  | 117.29% | 27.0 |  |
![]() | 46 | TENAX THERAPEUTICS INC. |  | 111.71% | 5.0 |  |
![]() | 47 | Corvus Pharmaceuticals Inc. |  | 111.16% | 163.0 |  |
 | 48 | NextCure Inc. |  | 110.19% | -7.0 |  |
![]() | 49 | GW PHARMACEUTICALS PLC |  | 107.18% | -18.0 |  |
 | 50 | MARIZYME INC |  | 106.73% | -26.0 |  |
 | 51 | Organogenesis Holdings Inc. |  | 105.47% | 60.0 |  |
 | 52 | Turning Point Therapeutics Inc. |  | 100.74% | 0.0 |  |
 | 53 | Shattuck Labs Inc. |  | 98.94% | 0.0 |  |
 | 54 | Atea Pharmaceuticals Inc. |  | 94.64% | 0.0 |  |
 | 55 | AMARIN CORP PLC\UK |  | 94.62% | -9.0 |  |
 | 56 | PLIANT THERAPEUTICS INC. |  | 92.65% | 0.0 |  |
 | 57 | Zoetis Inc. |  | 92.03% | -3.0 |  |
 | 58 | AVADEL PHARMACEUTICALS PLC |  | 91.36% | 82.0 |  |
![]() | 59 | Kura Oncology Inc. |  | 89.99% | 27.0 |  |
 | 60 | PFIZER INC |  | 88.97% | -13.0 |  |
 | 61 | Avidity Biosciences Inc. |  | 86.71% | 0.0 |  |
 | 62 | Xencor Inc |  | 82.97% | -42.0 |  |
 | 63 | Cryoport Inc. |  | 82.88% | 0.0 |  |
![]() | 64 | Akouos Inc. |  | 81.10% | 0.0 |  |
![]() | 65 | Viking Therapeutics Inc. |  | 80.62% | -32.0 |  |
 | 66 | BODY & MIND INC. |  | 80.24% | 0.0 |  |
 | 67 | Catalent Inc. |  | 77.79% | -63.0 |  |
 | 68 | Keros Therapeutics Inc. |  | 74.85% | 0.0 |  |
![]() | 69 | Dyne Therapeutics Inc. |  | 74.24% | 0.0 |  |
 | 70 | OPIANT PHARMACEUTICALS INC. |  | 73.32% | -64.0 |  |
 | 71 | ELI LILLY & Co |  | 72.30% | -21.0 |  |
 | 72 | PERRIGO Co plc |  | 70.19% | -15.0 |  |
 | 73 | LIGAND PHARMACEUTICALS INC |  | 69.25% | -62.0 |  |
 | 74 | Xenon Pharmaceuticals Inc. |  | 68.99% | 43.0 |  |
 | 75 | ALIMERA SCIENCES INC |  | 68.91% | 8.0 |  |
![]() | 76 | Pandion Therapeutics Inc. |  | 67.63% | 0.0 |  |
![]() | 77 | Stoke Therapeutics Inc. |  | 66.23% | -29.0 |  |
 | 78 | Frequency Therapeutics Inc. |  | 61.76% | -20.0 |  |
 | 79 | ChemoCentryx Inc. |  | 61.03% | 54.0 |  |
![]() | 80 | MERRIMACK PHARMACEUTICALS INC |  | 60.56% | 205.0 |  |
 | 81 | Elanco Animal Health Inc |  | 59.59% | -37.0 |  |
![]() | 82 | Vincerx Pharma Inc. |  | 58.01% | 0.0 |  |
 | 83 | Nurix Therapeutics Inc. |  | 57.29% | 0.0 |  |
 | 84 | COLLEGIUM PHARMACEUTICAL INC |  | 56.87% | -2.0 |  |
 | 85 | ARROWHEAD PHARMACEUTICALS INC. |  | 56.75% | -70.0 |  |
 | 86 | ARVINAS INC. |  | 56.26% | 5.0 |  |
 | 87 | MEDICINOVA INC |  | 55.89% | -27.0 |  |
![]() | 88 | Kronos Bio Inc. |  | 54.79% | 0.0 |  |
 | 89 | Karuna Therapeutics Inc. |  | 53.08% | -52.0 |  |
 | 90 | Arcturus Therapeutics Holdings Inc. |  | 51.51% | 54.0 |  |
 | 91 | Viatris Inc |  | 48.80% | 0.0 |  |
 | 92 | AYTU BIOPHARMA INC |  | 46.73% | 162.0 |  |
![]() | 93 | Repare Therapeutics Inc. |  | 46.16% | 0.0 |  |
![]() | 94 | Trillium Therapeutics Inc. |  | 40.76% | 0.0 |  |
 | 95 | IDEAYA Biosciences Inc. |  | 39.14% | 0.0 |  |
 | 96 | Altimmune Inc. |  | 37.29% | 46.0 |  |
 | 97 | PHIBRO ANIMAL HEALTH CORP |  | 36.74% | -35.0 |  |
 | 98 | NightHawk Biosciences Inc. |  | 30.54% | 159.0 |  |
 | 99 | ANI PHARMACEUTICALS INC |  | 30.38% | -38.0 |  |
 | 100 | LANDEC CORP \CA\ |  | 21.90% | -41.0 |  |
 | 101 | Protagonist Therapeutics Inc |  | 21.39% | 91.0 |  |
![]() | 102 | 89bio Inc. |  | 20.32% | 0.0 |  |
 | 103 | LANNETT CO INC | | 20.07% | 19.0 |  |
 | 104 | Amneal Pharmaceuticals Inc. | | 16.53% | -1.0 |  |
 | 105 | CHINOOK THERAPEUTICS INC. | | 14.04% | 36.0 |  |
 | 106 | ELITE PHARMACEUTICALS INC NV | | 13.38% | 0.0 |  |
 | 107 | Aurinia Pharmaceuticals Inc. | | 12.18% | 0.0 |  |
 | 108 | Arcus Biosciences Inc. | | 10.30% | 49.0 |  |
 | 109 | ASSEMBLY BIOSCIENCES INC. | | 7.46% | -4.0 |  |
 | 110 | Mirati Therapeutics Inc. | | 5.45% | 76.0 |  |
 | 111 | BRISTOL MYERS SQUIBB CO | | 4.48% | 0.0 |  |
 | 112 | VBI Vaccines Inc BC | | 4.27% | 56.0 |  |
 | 113 | Avid Bioservices Inc. | | 4.15% | -58.0 |  |
![]() | 114 | Prelude Therapeutics Inc | | 1.93% | 0.0 |  |
 | 115 | Emmaus Life Sciences Inc. | | 1.57% | 0.0 |  |
![]() | 116 | FIVE PRIME THERAPEUTICS INC. | | -1.23% | 118.0 |  |
![]() | 117 | Cellectar Biosciences Inc. | | -3.23% | 199.0 |  |
 | 118 | ROCKET PHARMACEUTICALS INC. | | -3.96% | -39.0 |  |
 | 119 | Bausch Health Companies Inc. | | -5.51% | -30.0 |  |
 | 120 | TREVENA INC | | -6.60% | 88.0 |  |
 | 121 | CHINA PHARMA HOLDINGS INC. | | -7.44% | 153.0 |  |
 | 122 | TEVA PHARMACEUTICAL INDUSTRIES LTD | | -9.82% | -46.0 |  |
![]() | 123 | Nkarta Inc. | | -9.93% | 0.0 |  |
 | 124 | Syndax Pharmaceuticals Inc | | -11.24% | 146.0 |  |
 | 125 | Harmony Biosciences Holdings Inc. | | -11.39% | 0.0 |  |
 | 126 | Morphic Holding Inc. | | -13.61% | -39.0 |  |
 | 127 | Assertio Holdings Inc. | | -19.31% | 0.0 |  |
![]() | 128 | ESSA Pharma Inc. | | -19.58% | 0.0 |  |
![]() | 129 | Lantern Pharma Inc. | | -22.06% | 0.0 |  |
![]() | 130 | Kindred Biosciences Inc. | | -22.98% | 0.0 |  |
 | 131 | Sonoma Pharmaceuticals Inc. | | -23.37% | 136.0 |  |
 | 132 | CytomX Therapeutics Inc. | | -23.65% | 14.0 |  |
 | 133 | ImmunoGen Inc. | | -26.31% | 54.0 |  |
 | 134 | GeoVax Labs Inc. | | -26.46% | 198.0 |  |
 | 135 | Adicet Bio Inc. | | -28.41% | 0.0 |  |
 | 136 | Cogent Biosciences Inc. | | -34.13% | 106.0 |  |
 | 137 | ORAMED PHARMACEUTICALS INC. | | -37.48% | 27.0 |  |
 | 138 | Salarius Pharmaceuticals Inc. | | -39.52% | 53.0 |  |
 | 139 | ALPINE IMMUNE SCIENCES INC. | | -39.80% | 119.0 |  |
 | 140 | BELLICUM PHARMACEUTICALS INC | | -43.53% | 125.0 |  |
 | 141 | GERON CORP | | -45.43% | 15.0 |  |
 | 142 | EXICURE INC. | | -46.31% | -49.0 |  |
![]() | 143 | Dicerna Pharmaceuticals Inc | | -47.92% | -27.0 |  |
 | 144 | FIBROGEN INC | | -47.94% | 0.0 |  |
 | 145 | IONIS PHARMACEUTICALS INC | | -49.18% | -109.0 |  |
 | 146 | Intra-Cellular Therapies Inc. | | -51.01% | 78.0 |  |
 | 147 | KalVista Pharmaceuticals Inc. | | -51.32% | -72.0 |  |
 | 148 | LEXICON PHARMACEUTICALS INC. | | -52.53% | -122.0 |  |
 | 149 | Matinas BioPharma Holdings Inc. | | -52.59% | 13.0 |  |
 | 150 | Mallinckrodt plc | | -53.16% | 0.0 |  |
 | 151 | Sarepta Therapeutics Inc. | | -54.22% | 10.0 |  |
 | 152 | Aptinyx Inc. | | -55.01% | 51.0 |  |
 | 153 | MusclePharm Corp | | -55.25% | 109.0 |  |
 | 154 | Atreca Inc. | | -55.79% | -36.0 |  |
 | 155 | RIGEL PHARMACEUTICALS INC | | -56.55% | 24.0 |  |
![]() | 156 | Zentalis Pharmaceuticals Inc. | | -56.86% | 0.0 |  |
 | 157 | NGM BIOPHARMACEUTICALS INC | | -57.19% | -105.0 |  |
 | 158 | Verona Pharma plc | | -58.92% | 0.0 |  |
 | 159 | MEI Pharma Inc. | | -59.07% | -65.0 |  |
 | 160 | BeiGene Ltd. | | -60.13% | 63.0 |  |
![]() | 161 | CymaBay Therapeutics Inc. | | -60.84% | 27.0 |  |
![]() | 162 | Inozyme Pharma Inc. | | -61.09% | 0.0 |  |
 | 163 | NEKTAR THERAPEUTICS | | -62.19% | -73.0 |  |
 | 164 | Actinium Pharmaceuticals Inc. | | -63.64% | 170.0 |  |
![]() | 165 | ARENA PHARMACEUTICALS INC | | -63.83% | -163.0 |  |
 | 166 | Foghorn Therapeutics Inc. | | -64.95% | 0.0 |  |
 | 167 | Seres Therapeutics Inc. | | -66.41% | 34.0 |  |
 | 168 | Mersana Therapeutics Inc. | | -66.91% | -68.0 |  |
 | 169 | RVL Pharmaceuticals plc | | -67.86% | 48.0 |  |
 | 170 | DYNAVAX TECHNOLOGIES CORP | | -72.71% | 36.0 |  |
![]() | 171 | Metacrine Inc. | | -76.30% | 0.0 |  |
 | 172 | Sesen Bio Inc. | | -79.32% | 89.0 |  |
 | 173 | ALNYLAM PHARMACEUTICALS INC. | | -82.14% | -24.0 |  |
 | 174 | CYTOKINETICS INC | | -82.40% | 3.0 |  |
 | 175 | Zymeworks Inc. | | -84.62% | -20.0 |  |
 | 176 | GLYCOMIMETICS INC | | -86.49% | -55.0 |  |
 | 177 | MACROGENICS INC | | -87.22% | 8.0 |  |
 | 178 | Fortress Biotech Inc. | | -87.45% | 2.0 |  |
![]() | 179 | Equillium Inc. | | -88.80% | -5.0 |  |
 | 180 | BioXcel Therapeutics Inc. | | -91.12% | 107.0 |  |
 | 181 | Travere Therapeutics Inc. | | -91.44% | -61.0 |  |
 | 182 | Monopar Therapeutics | | -92.31% | -78.0 |  |
 | 183 | BICYCLE THERAPEUTICS plc | | -92.98% | -86.0 |  |
 | 184 | uniQure N.V. | | -94.13% | -74.0 |  |
![]() | 185 | ZOGENIX INC. | | -95.30% | 112.0 |  |
 | 186 | ACADIA PHARMACEUTICALS INC | | -96.79% | -84.0 |  |
 | 187 | PUMA BIOTECHNOLOGY INC. | | -101.24% | -34.0 |  |
 | 188 | PROTHENA CORP PUBLIC LTD CO | | -103.26% | -103.0 |  |
 | 189 | Global Blood Therapeutics Inc. | | -106.26% | -55.0 |  |
 | 190 | AMICUS THERAPEUTICS INC. | | -107.36% | -24.0 |  |
![]() | 191 | IVERIC bio Inc. | | -109.56% | -22.0 |  |
 | 192 | Syros Pharmaceuticals Inc. | | -111.31% | 1.0 |  |
![]() | 193 | Immunome Inc. | | -112.94% | 0.0 |  |
![]() | 194 | Societal CDMO Inc. | | -115.12% | -71.0 |  |
 | 195 | Aptevo Therapeutics Inc. | | -118.92% | 56.0 |  |
 | 196 | VERU INC. | | -120.34% | -98.0 |  |
 | 197 | Merus N.V. | | -121.89% | -96.0 |  |
![]() | 198 | Larimar Therapeutics Inc. | | -123.35% | 14.0 |  |
![]() | 199 | Strongbridge Biopharma plc | | -125.54% | -34.0 |  |
 | 200 | PIERIS PHARMACEUTICALS INC. | | -126.90% | -101.0 |  |
![]() | 201 | Citius Pharmaceuticals Inc. | | -126.98% | 0.0 |  |
 | 202 | Deciphera Pharmaceuticals Inc. | | -130.63% | -93.0 |  |
 | 203 | SYNLOGIC INC. | | -131.90% | -107.0 |  |
 | 204 | F-star Therapeutics Inc. | | -132.00% | 0.0 |  |
![]() | 205 | Hepion Pharmaceuticals Inc. | | -134.10% | -79.0 |  |
 | 206 | AGIOS PHARMACEUTICALS INC. | | -136.23% | -31.0 |  |
 | 207 | Apellis Pharmaceuticals Inc. | | -136.91% | 46.0 |  |
 | 208 | ALBIREO PHARMA INC. | | -137.55% | -56.0 |  |
 | 209 | Revance Therapeutics Inc. | | -137.61% | -28.0 |  |
 | 210 | DiaMedica Therapeutics Inc. | | -141.16% | 110.0 |  |
 | 211 | Regulus Therapeutics Inc. | | -143.29% | -38.0 |  |
 | 212 | CHEMBIO DIAGNOSTICS INC. | | -143.65% | -93.0 |  |
 | 213 | ROCKWELL MEDICAL INC. | | -144.76% | 43.0 |  |
![]() | 214 | ATOSSA THERAPEUTICS INC. | | -145.26% | 109.0 |  |
 | 215 | Mirum Pharmaceuticals Inc. | | -148.61% | -83.0 |  |
 | 216 | G1 Therapeutics Inc. | | -148.62% | -58.0 |  |
 | 217 | OTONOMY INC. | | -148.68% | -15.0 |  |
 | 218 | RAPT Therapeutics Inc. | | -150.34% | 0.0 |  |
 | 219 | Verastem Inc. | | -153.12% | 57.0 |  |
 | 220 | TG THERAPEUTICS INC. | | -153.84% | 68.0 |  |
![]() | 221 | IMARA Inc. | | -154.45% | 0.0 |  |
 | 222 | iBio Inc. | | -154.54% | -8.0 |  |
![]() | 223 | REVIVA PHARMACEUTICALS HOLDINGS INC. | | -155.04% | 0.0 |  |
![]() | 224 | Arcutis Biotherapeutics Inc. | | -155.36% | 0.0 |  |
![]() | 225 | CHIASMA INC | | -155.40% | 0.0 |  |
![]() | 226 | Phathom Pharmaceuticals Inc. | | -156.75% | 84.0 |  |
![]() | 227 | Kiniksa Pharmaceuticals Ltd. | | -161.35% | 19.0 |  |
 | 228 | Magenta Therapeutics Inc. | | -162.83% | -50.0 |  |
 | 229 | Aravive Inc. | | -162.87% | -148.0 |  |
![]() | 230 | Applied Molecular Transport Inc. | | -168.64% | 0.0 |  |
 | 231 | Esperion Therapeutics Inc. | | -171.58% | -49.0 |  |
 | 232 | TFF Pharmaceuticals Inc. | | -171.62% | -84.0 |  |
 | 233 | SELECTA BIOSCIENCES INC | | -171.71% | 0.0 |  |
 | 234 | Zosano Pharma Corp | | -172.45% | 43.0 |  |
 | 235 | ARDELYX INC. | | -176.34% | -92.0 |  |
![]() | 236 | ENDONOVO THERAPEUTICS INC. | | -177.84% | 86.0 |  |
![]() | 237 | AMERICAN BIO MEDICA CORP | | -180.63% | 0.0 |  |
![]() | 238 | Flexion Therapeutics Inc | | -184.48% | 0.0 |  |
 | 239 | Homology Medicines Inc. | | -185.40% | -114.0 |  |
![]() | 240 | Bellerophon Therapeutics Inc. | | -187.44% | 42.0 |  |
 | 241 | Aeglea BioTherapeutics Inc. | | -190.50% | 53.0 |  |
![]() | 242 | RELMADA THERAPEUTICS INC. | | -191.53% | 94.0 |  |
![]() | 243 | NeuBase Therapeutics Inc. | | -192.36% | 104.0 |  |
 | 244 | INTERCEPT PHARMACEUTICALS INC. | | -196.15% | -60.0 |  |
 | 245 | Savara Inc | | -196.28% | -25.0 |  |
![]() | 246 | REGENEREX PHARMA INC. | | -197.30% | 0.0 |  |
 | 247 | Spero Therapeutics Inc. | | -197.44% | -29.0 |  |
 | 248 | YUMANITY THERAPEUTICS INC. | | -197.82% | 4.0 |  |
 | 249 | Summit Therapeutics Inc. | | -198.47% | 0.0 |  |
![]() | 250 | Adamas Pharmaceuticals Inc | | -198.64% | -22.0 |  |
 | 251 | LEAP THERAPEUTICS INC. | | -198.81% | 101.0 |  |
 | 252 | Pulmatrix Inc. | | -199.02% | -39.0 |  |
![]() | 253 | Tonix Pharmaceuticals Holding Corp. | | -199.60% | 88.0 |  |
 | 254 | CHIMERIX INC | | -199.97% | 50.0 |  |
 | 255 | International Stem Cell CORP | | -209.22% | -24.0 |  |
 | 256 | AVEO PHARMACEUTICALS INC. | | -214.45% | -218.0 |  |
 | 257 | OptiNose Inc. | | -214.51% | -25.0 |  |
![]() | 258 | MANNKIND CORP | | -216.73% | -51.0 |  |
 | 259 | Wave Life Sciences Ltd. | | -217.46% | -15.0 |  |
 | 260 | KIORA PHARMACEUTICALS INC | | -218.21% | -10.0 |  |
 | 261 | SCYNEXIS INC | | -218.32% | 7.0 |  |
 | 262 | Checkpoint Therapeutics Inc. | | -219.99% | 24.0 |  |
 | 263 | Paratek Pharmaceuticals Inc. | | -221.33% | -65.0 |  |
 | 264 | Fulcrum Therapeutics Inc. | | -223.00% | -4.0 |  |
![]() | 265 | MUSTANG BIO INC. | | -223.10% | -29.0 |  |
 | 266 | Alaunos Therapeutics Inc. | | -223.25% | 0.0 |  |
![]() | 267 | Radius Health Inc. | | -228.63% | 0.0 |  |
 | 268 | ABEONA THERAPEUTICS INC. | | -229.38% | -137.0 |  |
![]() | 269 | XERIS PHARMACEUTICALS INC | | -233.99% | 26.0 |  |
 | 270 | PLx Pharma Inc. | | -234.95% | 19.0 |  |
![]() | 271 | NANOVIRICIDES INC. | | -235.20% | -34.0 |  |
 | 272 | Celsion CORP | | -236.83% | -96.0 |  |
![]() | 273 | Aprea Therapeutics Inc. | | -238.32% | -196.0 |  |
 | 274 | ACELRX PHARMACEUTICALS INC | | -239.21% | 0.0 |  |
 | 275 | EYENOVIA INC. | | -241.60% | 53.0 |  |
 | 276 | ACURA PHARMACEUTICALS INC | | -243.18% | 0.0 |  |
![]() | 277 | Genprex Inc. | | -244.14% | 80.0 |  |
 | 278 | Clovis Oncology Inc. | | -244.18% | -59.0 |  |
 | 279 | OCULAR THERAPEUTIX INC | | -244.92% | 2.0 |  |
 | 280 | Akebia Therapeutics Inc. | | -246.85% | -130.0 |  |
 | 281 | Innovation1 Biotech Inc. | | -247.24% | 0.0 |  |
 | 282 | Moleculin Biotech Inc. | | -252.38% | -83.0 |  |
 | 283 | Unity Biotechnology Inc. | | -252.45% | -79.0 |  |
 | 284 | Theravance Biopharma Inc. | | -252.74% | -63.0 |  |
 | 285 | Edesa Biotech Inc. | | -253.02% | 0.0 |  |
 | 286 | CATALYST BIOSCIENCES INC. | | -254.74% | -77.0 |  |
 | 287 | Novan Inc. | | -255.08% | 0.0 |  |
 | 288 | IntelGenx Technologies Corp. | | -256.05% | -24.0 |  |
 | 289 | Liquidia Corp | | -256.99% | 0.0 |  |
 | 290 | Karyopharm Therapeutics Inc. | | -257.19% | -50.0 |  |
 | 291 | BridgeBio Pharma Inc. | | -279.92% | -124.0 |  |
![]() | 292 | KEMPHARM INC | | -281.12% | -29.0 |  |
![]() | 293 | Immune Therapeutics Inc. | | -281.25% | -20.0 |  |
 | 294 | HERON THERAPEUTICS INC. DE | | -281.44% | -143.0 |  |
![]() | 295 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | | -284.38% | 3.0 |  |
![]() | 296 | GENEREX BIOTECHNOLOGY CORP | | -299.35% | 0.0 |  |
 | 297 | Evolus Inc. | | -302.22% | -138.0 |  |
![]() | 298 | Intec Pharma Ltd. | | -303.56% | 47.0 |  |
![]() | 299 | Kadmon Holdings Inc. | | -304.61% | -192.0 |  |
 | 300 | BIO-PATH HOLDINGS INC | | -308.77% | -161.0 |  |
 | 301 | CV Sciences Inc. | | -312.32% | -166.0 |  |
 | 302 | Cyclerion Therapeutics Inc. | | -313.79% | -53.0 |  |
![]() | 303 | SANGUI BIOTECH INTERNATIONAL INC | | -313.98% | 5.0 |  |
 | 304 | Advaxis Inc. | | -316.89% | -168.0 |  |
 | 305 | Aclaris Therapeutics Inc. | | -319.03% | 28.0 |  |
![]() | 306 | Annovis Bio Inc. | | -319.18% | 0.0 |  |
![]() | 307 | Ampio Pharmaceuticals Inc. | | -320.54% | -23.0 |  |
 | 308 | Aquestive Therapeutics Inc. | | -321.15% | -53.0 |  |
 | 309 | AGILE THERAPEUTICS INC | | -322.86% | -171.0 |  |
![]() | 310 | Molecular Templates Inc. | | -327.28% | -150.0 |  |
 | 311 | Aditxt Inc. | | -329.79% | 0.0 |  |
 | 312 | Zynerba Pharmaceuticals Inc. | | -330.15% | -167.0 |  |
 | 313 | Calithera Biosciences Inc. | | -340.62% | -113.0 |  |
 | 314 | NovaBay Pharmaceuticals Inc. | | -344.41% | -55.0 |  |
 | 315 | Jaguar Health Inc. | | -345.61% | -13.0 |  |
 | 316 | Benitec Biopharma Inc. | | -348.04% | 0.0 |  |
 | 317 | TherapeuticsMD Inc. | | -361.85% | -84.0 |  |
![]() | 318 | Sio Gene Therapies Inc. | | -364.25% | -22.0 |  |
 | 319 | OMEROS CORP | | -368.99% | -90.0 |  |
 | 320 | vTv Therapeutics Inc. | | -370.79% | 5.0 |  |
 | 321 | INFINITY PHARMACEUTICALS INC. | | -373.35% | -52.0 |  |
 | 322 | SOLIGENIX INC. | | -375.45% | -19.0 |  |
 | 323 | ABVC BIOPHARMA INC. | | -376.17% | -118.0 |  |
![]() | 324 | Sierra Oncology Inc. | | -377.23% | 0.0 |  |
![]() | 325 | PROVECTUS BIOPHARMACEUTICALS INC. | | -384.64% | 0.0 |  |
 | 326 | Lipocine Inc. | | -385.94% | -87.0 |  |
 | 327 | SPECTRUM PHARMACEUTICALS INC | | -387.17% | -164.0 |  |
![]() | 328 | GALECTIN THERAPEUTICS INC | | -392.24% | -240.0 |  |
![]() | 329 | America Great Health | | -401.52% | 0.0 |  |
 | 330 | Biohaven Pharmaceutical Holding Co Ltd. | | -408.13% | 0.0 |  |
 | 331 | Entasis Therapeutics Holdings Inc. | | -416.50% | -52.0 |  |
 | 332 | Clearside Biomedical Inc. | | -430.33% | -26.0 |  |
![]() | 333 | Teligent Inc. | | -431.21% | -225.0 |  |
![]() | 334 | BIORA THERAPEUTICS INC. | | -432.51% | 0.0 |  |
 | 335 | Xenetic Biosciences Inc. | | -435.40% | -108.0 |  |
![]() | 336 | NUGENEREX IMMUNO-ONCOLOGY INC. | | -440.85% | 0.0 |  |
 | 337 | CTI BIOPHARMA CORP | | -441.88% | -71.0 |  |
 | 338 | Guardion Health Sciences Inc. | | -453.92% | -67.0 |  |
![]() | 339 | Applied Therapeutics Inc. | | -458.91% | -47.0 |  |
 | 340 | Iterum Therapeutics plc | | -459.36% | 4.0 |  |
 | 341 | SEELOS THERAPEUTICS INC. | | -461.01% | 15.0 |  |
 | 342 | Y-mAbs Therapeutics Inc. | | -466.65% | -205.0 |  |
![]() | 343 | REGENERX BIOPHARMACEUTICALS INC | | -473.13% | -63.0 |  |
![]() | 344 | CARDAX INC. | | -486.55% | -43.0 |  |
 | 345 | Viracta Therapeutics Inc. | | -495.60% | -110.0 |  |
 | 346 | Corbus Pharmaceuticals Holdings Inc. | | -504.60% | -29.0 |  |
 | 347 | PREDICTIVE TECHNOLOGY GROUP INC. | | -511.39% | -284.0 |  |
 | 348 | Brooklyn ImmunoTherapeutics Inc. | | -513.19% | -256.0 |  |
 | 349 | Evoke Pharma Inc | | -515.73% | -36.0 |  |
 | 350 | Ovid Therapeutics Inc. | | -519.34% | 0.0 |  |
 | 351 | Eton Pharmaceuticals Inc. | | -521.05% | -44.0 |  |
![]() | 352 | Kaya Holdings Inc. | | -523.95% | 0.0 |  |
 | 353 | UroGen Pharma Ltd. | | -563.02% | -157.0 |  |
![]() | 354 | Vicapsys Life Sciences Inc. | | -573.17% | 0.0 |  |
![]() | 355 | Rebus Holdings Inc. | | -590.65% | -107.0 |  |
![]() | 356 | ARTELO BIOSCIENCES INC. | | -593.86% | -232.0 |  |
 | 357 | Statera Biopharma Inc. | | -598.01% | -36.0 |  |
 | 358 | Histogen Inc. | | -599.07% | -161.0 |  |
 | 359 | Anixa Biosciences Inc | | -599.24% | -17.0 |  |
![]() | 360 | Synthetic Biologics Inc. | | -610.40% | -82.0 |  |
![]() | 361 | Cell Source Inc. | | -615.82% | 0.0 |  |
![]() | 362 | RespireRx Pharmaceuticals Inc. | | -639.65% | -79.0 |  |
 | 363 | ATHERSYS INC NEW | | -673.71% | 0.0 |  |
![]() | 364 | ONCOSEC MEDICAL Inc | | -682.13% | -55.0 |  |
 | 365 | Adamis Pharmaceuticals Corp | | -686.30% | 0.0 |  |
 | 366 | HUMANIGEN INC | | -688.37% | -40.0 |  |
 | 367 | Innovation Pharmaceuticals Inc. | | -691.06% | 0.0 |  |
![]() | 368 | CANNAPHARMARX INC. | | -695.28% | -56.0 |  |
![]() | 369 | GlobeStar Therapeutics Corp | | -697.12% | -45.0 |  |
![]() | 370 | BIOADAPTIVES INC. | | -699.83% | 0.0 |  |
![]() | 371 | AILERON THERAPEUTICS INC | | -706.99% | -60.0 |  |
![]() | 372 | BIOVIE INC. | | -711.87% | -72.0 |  |
![]() | 373 | Urovant Sciences Ltd. | | -714.23% | -58.0 |  |
 | 374 | Avalo Therapeutics Inc. | | -733.26% | -202.0 |  |
 | 375 | Timber Pharmaceuticals Inc. | | -741.12% | 0.0 |  |
 | 376 | AgeX Therapeutics Inc. | | -760.20% | 0.0 |  |
 | 377 | MADRIGAL PHARMACEUTICALS INC. | | -783.07% | -306.0 |  |
 | 378 | Acer Therapeutics Inc. | | -798.63% | -51.0 |  |
 | 379 | Lexaria Bioscience Corp. | | -872.85% | -41.0 |  |
 | 380 | VACCINEX INC. | | -922.57% | -22.0 |  |
![]() | 381 | BIOXYTRAN INC | | -941.13% | -33.0 |  |
![]() | 382 | First Wave BioPharma Inc. | | -953.82% | -53.0 |  |
 | 383 | CytoDyn Inc. | | -981.19% | -48.0 |  |
![]() | 384 | Chemomab Therapeutics Ltd. | | -983.89% | -381.0 |  |
![]() | 385 | CQENS Technologies Inc. | | -993.92% | -191.0 |  |
![]() | 386 | Wellness Center USA Inc. | | -994.56% | -37.0 |  |
 | 387 | Ainos Inc. | | -1002.55% | -50.0 |  |
![]() | 388 | Earth Science Tech Inc. | | -1018.83% | -33.0 |  |
![]() | 389 | Rezolute Inc. | | -1022.32% | -49.0 |  |
 | 390 | VistaGen Therapeutics Inc. | | -1049.49% | -59.0 |  |
![]() | 391 | Skye Bioscience Inc. | | -1068.56% | -379.0 |  |
![]() | 392 | Synaptogenix Inc. | | -1098.17% | 0.0 |  |
![]() | 393 | ADIAL PHARMACEUTICALS INC. | | -1138.83% | -74.0 |  |
![]() | 394 | Propanc Biopharma Inc. | | -1190.35% | -48.0 |  |
![]() | 395 | NORTHWEST BIOTHERAPEUTICS INC | | -1191.54% | -120.0 |  |
![]() | 396 | Greater Cannabis Company Inc. | | -1302.92% | -57.0 |  |
![]() | 397 | Kintara Therapeutics Inc. | | -1309.86% | 0.0 |  |
![]() | 398 | HST Global Inc. | | -1321.91% | 0.0 |  |
 | 399 | VYNE Therapeutics Inc. | | -1333.06% | -100.0 |  |
![]() | 400 | Nascent Biotech Inc. | | -1347.62% | 0.0 |  |
 | 401 | Orgenesis Inc. | | -1409.58% | -272.0 |  |
![]() | 402 | NeuroBo Pharmaceuticals Inc. | | -1528.07% | -72.0 |  |
![]() | 403 | Scopus BioPharma Inc. | | -1598.29% | 0.0 |  |
![]() | 404 | Rasna Therapeutics Inc. | | -1798.87% | -309.0 |  |
 | 405 | One World Products Inc. | | -2015.09% | -45.0 |  |
 | 406 | CNBX Pharmaceuticals Inc. | | -2970.22% | -398.0 |  |
![]() | 407 | Q BioMed Inc. | | -4819.16% | -57.0 |  |
![]() | 408 | ProtoKinetix Inc. | | -11891.70% | -47.0 |  |
![]() | 409 | NEXIEN BIOPHARMA INC. | | -41795.90% | -47.0 |  |